Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBNP for Coronary Microcirculation in STEMI
NCT05723315Not yet recruiting
- Sponsor
- Henan Institute of Cardiovascular Epidemiology
- Start
- Feb 2023
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised trial of nesiritide in ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Henan Institute of Cardiovascular Epidemiology. Primary endpoint: Microvascular Obstruction/Left Ventricular Mass. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
nesiritide
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT05723315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05723315.